Foundation Fighting Blindness

Foundation Fighting Blindness

Eye on the Cure | Episode 104: Dr. Daniel Chung – Emerging XLRP gene therapy shows promising results

OCT 21, 202637 MIN

Description

Host Maddie Mossman talks with Dr. Daniel Chung, Chief Medical Officer of Beacon Therapeutics, about Laru-zova, an emerging treatment for X-linked retinitis pigmentosa. Based on encouraging clinical trial results, Beacon plans to begin a rolling FDA submission for the potential gene therapy later this year. The Foundation funded pre-clinical research that went on to became laru-zova.